Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Addressing Challenges: Adopting Blockchain in the Pharmaceutical Industry for Enhanced Sustainability

Version 1 : Received: 30 December 2023 / Approved: 16 January 2024 / Online: 17 January 2024 (05:18:23 CET)

A peer-reviewed article of this Preprint also exists.

Riedel, T. Addressing Challenges: Adopting Blockchain Technology in the Pharmaceutical Industry for Enhanced Sustainability. Sustainability 2024, 16, 3102. Riedel, T. Addressing Challenges: Adopting Blockchain Technology in the Pharmaceutical Industry for Enhanced Sustainability. Sustainability 2024, 16, 3102.

Abstract

The growing importance of sustainability in organizational success, particularly in the pharma-ceutical industry, underscores the need for leveraging technologies like blockchain to enhance sustainability indicators across environmental, social, and economic pillars. This study aims to identify and understand the challenges hindering the adoption of blockchain in the pharmaceuti-cal sector for improving sustainability performance, addressing two research questions: the spe-cific challenges faced by blockchain adoption in this context and the interdependencies among these challenges. Employing a two-step approach, the study compiles challenges through a litera-ture review, refines them via expert opinions, and establishes their interrelationships using methodologies like Fuzzy Interpretive Structural Modeling (FISM) and Cross-Impact Matrix Multiplication Applied to Classification (MICMAC). The research contributes to unraveling the complex relationships and dependencies within the system, providing a structured framework for improved decision-making and strategic planning. It fills a literature gap by being the first attempt to outline driving and dependent factors related to the challenges of adopting blockchain technology for sustainability enhancement in the pharmaceutical sector, offering insights that can significantly impact brand image, company perception, and consumer value.

Keywords

Blockchain; fuzzy-ISM; MICMAC; pharmaceutical industry; sustainability

Subject

Business, Economics and Management, Business and Management

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.